Specialist teams work together to deliver the highest quality products and services to the industry.
Claudia Zylberberg, PhD; Founder and CEO
Dr. Zylberberg has more than 25 years’ experience in the biomedical research and biotechnology industries, and first-hand knowledge of what it takes to bring products through R&D, and on to approval and commercialization. She is highly knowledgeable about current FDA regulations, qualification of raw materials, process design and validation, and bioassay development.
Dr. Zylberberg is proud to act as advisor and consultant to organizations worldwide regarding the regulatory roadmap and commercialization of cell therapies and stem cell banking. In addition, she brings her expertise in recombinant proteins, media development, combinational (devices), and platform technologies to
Dr. Zylberberg is affiliated with the International Society for Cell Therapy (ISCT) and holds many nonexecutive positions: Board Member and Scientific Advisor,